Ventac Partners
Robert L. Buchanan is a seasoned professional in the life sciences and biotechnology sectors, currently serving as co-founder and board member for RORA Biologics and Ambulero since 2021 and 2019 respectively. At the University of Miami, Buchanan acts as Entrepreneur In Residence and is a member of the Oversight Committee at the Wallace H. Coulter Center for Translational Research. With extensive experience in intellectual property as Associate General Counsel at Biogen and General Counsel at Avexxin AS, Buchanan co-founded Regenesance BV and Idogen AB, contributing significantly to the development of innovative therapeutic solutions. Buchanan's educational background includes a Ph.D. in Biochemistry from UCLA, a Juris Doctor from Suffolk University Law School, and a BS in Biochemistry from the University of Massachusetts Amherst.
This person is not in any offices
Ventac Partners
1 followers
With offices across Europe, United States and Asia and with our multi-disciplinary Partner and Advisor teams, Ventac Partners strives to provide its clients superior global services delivered locally. Covering Biotech, Pharma and Medtech, we offer hands-on experience and skills required to drive innovative technology-based projects from the laboratory to the market. Over the last 15 years, we have experienced a steadily growing business with industry and academic institutions, we have founded, incorporated and exited several companies together with our partners and investors and consulted on hundreds of different early stage or advanced projects. Ventac Partners is continuously expanding its international presence and remains committed to generate value to its clients and portfolio company partners and investors.